Viatris vs Medtronic

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (88 vs 90)
Viatris logo

Viatris

LeaderHealthcare Tech

Generic Pharmaceuticals

Viatris (VTRS) reported ~$15.4B revenue in FY2024. Global generic and specialty pharmaceutical company formed by Pfizer's Upjohn spinoff merging with Mylan. HQ: Canonsburg, PA.

AI VisibilityBeta
Overall Score
A88
Category Rank
#1 of 1
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
98
Perplexity
98
Gemini
88

About

Viatris Inc. is a global pharmaceutical company formed in 2020 through the combination of Pfizer's off-patent branded drug unit (Upjohn) and Mylan, one of the world's largest generic drug manufacturers. The company manufactures, licenses, and distributes approximately 1,400 approved molecules across branded generics, complex generics, and a portfolio of iconic off-patent brands including Lipitor (atorvastatin), Viagra (sildenafil), EpiPen, and Xanax (alprazolam) sold in markets where these brands retain meaningful recognition and premium pricing.

Full profile
Medtronic logo

Medtronic

LeaderHealthcare Tech

Enterprise

World's largest medical device company with $32.4B FY2024 revenue; Hugo robotic surgery challenges Intuitive Surgical; MiniMed automated insulin system; Patient Monitoring spin-off 2024; NYSE: MDT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#126 of 290
AI Consensus
53%
Trend
up
Per Platform
ChatGPT
85
Perplexity
97
Gemini
99

About

Medtronic plc is the world's largest medical device company, founded in 1949 by Earl Bakken and Palmer Hermundslie in a Minneapolis, Minnesota garage—where Bakken invented the first wearable external pacemaker—and now incorporated in Ireland with operational headquarters in Dublin, trading on NYSE (MDT). The company generated approximately $32.4 billion in revenues for fiscal year 2024 (ending April 26, 2024) under CEO Geoff Martha, spanning cardiovascular, neuroscience, surgical, and diabetes therapy technologies. Medtronic's 2015 acquisition of Covidien for $49.9 billion—at the time the largest medical device merger in history—added surgical instruments, patient monitoring, and respiratory interventions while enabling Irish incorporation that reduced the company's effective tax rate. In 2024, Medtronic announced the spin-off of its Patient Monitoring & Respiratory Interventions segment as an independent company (NewCo), sharpening focus on higher-margin, high-growth therapy areas.

Full profile

AI Visibility Head-to-Head

88
Overall Score
90
#1
Category Rank
#126
58
AI Consensus
53
stable
Trend
up
98
ChatGPT
85
98
Perplexity
97
88
Gemini
99
88
Claude
97
82
Grok
82

Key Details

Category
Generic Pharmaceuticals
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Viatris
Generic Pharmaceuticals

Integrations

Both integrate with
Only Medtronic
Viatris is classified as company (part of Pfizer). Medtronic is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.